RHÃN-KLINIKUM AG 11.03.2014 14:31 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification according to section 26 para. 1 WpHG Morgan Stanley, Wilmington/Delaware, USA notified us pursuant to section 21 WpHG and pursuant to section 25 WpHG of the following: 1) Morgan Stanley notified us pursuant to section 21 WpHG of the following: On March 03, 2014, Morgan Stanley exceeded the threshold of 5% of the voting rights in RHÃN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley held 5.27% of the voting rights in RHÃN-KLINIKUM AG arising from 7,279,027 voting rights. Of these voting rights, a proportion of 4.76 (equals 6,584,530 voting rights) is attributed to Morgan Stanley pursuant to section 22 para. 1 sent. 1 no. 1 WpHG and a proportion of 0.50% (equals 694,497 voting rights) is attributed to Morgan Stanley pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG (names of controlled undertakings: Morgan Stanley Capital Management LLC; Morgan Stanley Domestic Holdings Inc.; Morgan Stanley & Co. LLC). 2) Morgan Stanley notified us pursuant to section 25 WpHG of the following: On March 03, 2014 Morgan Stanley exceeded the threshold of 5% of the voting rights of RHÃN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley held 5.30% of the voting rights in RHÃN-KLINIKUM AG (equals 7,329,176 voting rights). From these voting rights a proportion of 5.27% (equals 7,279,027 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 0.04% (equals 50,149 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.04% (equals 50,149 voting rights) is held indirectly (chain of controlled undertakings: Morgan Stanley Capital Management LLC; Morgan Stanley Domestic Holdings Inc.; Morgan Stanley & Co. LLC). The instruments pursuant to section 25 WpHG are retransfer claims based on various contracts that can be exercised at the lenders discretion. Bad Neustadt a.d. Saale, March 11, 2014 The Board of Management ___________________________________________________________________________ Dr. Kai G. Klinger Head of Investor Relations RHÃN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Phone: +49 9771 65 - 1318 Fax: +49 9771 99 - 1736 11.03.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: RHÃN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Internet: www.rhoen-klinikum-ag.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: RHÃN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
| Source: EQS Group AG